Showing 1–14 of 14 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Nigussie Assefa Kassaw, Jemal Haidar, Dawit Getachew Assefa, Daniel Fiseha, Dereje Habte, et al.
…sis (MDR-TB) and Tuberculosis/Human Immunodeficiency Virus (TB/HIV). Given the public health importance of the problem, it is apparent that probing the work done in this regard is essential to mitigate the problem and thus we reviewed research repositories and compile directories…
N. A. Sosova, T. A. Zadremaylova, Н. М. Коновалова, A. V. Abramchenko, M. I. Romanova, et al.
…stant tuberculosis (MDR, pre-XDR, XDR and HIV infection (DR TB/HIV Group ) and 707 patients with drug resistant tuberculosis (MDR, pre-XDR, and XDR) (and negative HIV status (DR TB Group). The immune status of patients in DR TB/HIV Group and its impact on the effectiveness of tub…
O. V. Filinyuk, A. S. Аlliluev, D. E. Аmichba, П. Н. Голубчиков, Yu. S. Popelo, et al.
…on, the level of primary MDR reaches 31.3% in patients with TB/HIV co-infection, while in HIV negative tuberculosis patients, this rate is 24.2%. The incidence of primary MDR/XDR MTB reaches 40% among deceased patients with TB/HIV co-infection. Treatment efficacy in MDR/XDR TB pa…
Margherita Bracchi, Clare van Halsema, Frank A. Post, Funmi Awosusi, Alison Barbour, et al.
…tlined in Appendix 2. BHIVA guidelines for the treatment of TB/HIV co-infection were last published in 2011 4. For the 2017 guidelines, Medline, EMBASE and the Cochrane Library were searched between August 2015 and January 2016. Abstracts from selected conferences (see Appendix 2…
M.І. Sakhelashvili, Z.I. Pіskur, O.I. Sakhelashvili–Bil, I. V. Yurchenko
…ted to disability in 24.4 % (10) of patients with sensitive TB/HIV and in 55.7 % (34) with chemoresistant TB/HIV or even death in 11.9 % and 26.2 %, respectively.
N.А. Lytvynenko, Yu. I. Feshchenko, Maryna Pohrebna, Yu.О. Senko, Л.М. Процик, et al.
…nts in the outpatient phase of treatment. Immunodeficiency (TB/HIV co-infection) is not the main factor in reducing efficiency: the proportion of HIV deaths has remained unchanged over the past 10 years.Conclusions. All the studied trends are a modern pathomorphosis of tuberculos…
World Health Organization. Regional Office for South-East Asia
…nd treatment success; establishing interventions to address TB/HIV and MDR-TB; forging partnerships to ensure equitable access to an essential standard of care to all TB patients, and contributing to strengthening health systems. Member countries have also developed national plan…
World Health Organization. Regional Office for Europe
…pdates on DR-TB treatment and related topics, in particular TB/HIV and paediatric TB and latent TB infection (LTBI) management and their implications for laboratory diagnosis, drug supply, infection control and clinical follow-up. The WHO Regional Office and Global TB Programme a…
Abenezer Abraham Anito, Gemechis Abdissa, Yohannis Gezahegn, Ebrahim Umer Muhammed, Hunde Lemi
…sitivity analysis. Targeted adherence support, strengthened TB/HIV integration, and improved programmatic monitoring are essential to further reduce mortality and loss to follow-up.
World Health Organization. Regional Office for Europe
…nsively drug-resistant TB (M/XDR-TB), the growing number of TB/HIV coinfection cases and the challenges in reforming health-care systems towards ambulatory TB care.RecommendationsTB and universal health coverage (UHC): To support countries’ efforts to end TB under UHC, TAG-TB rec…
Érica Chimara, Pedro Eduardo Almeida da Silva, Kleydson Bonfim Andrade Alves, Andréa Villarino, Gabriela Gago, et al.
… health service organization factors.Thus, problems such as TB/HIV coinfection, the increase in diabetes, smoking and other chronic diseases are added to factors such as malnutrition, the use of psychoactive substances and limited access to health services.These factors are accen…
Natália Rocha Almeida, Caio Azevedo Lima, Natália Lopes de Freitas, Fabiana Brandão
…vertheless, children show better outcomes among patients in TB/HIV co-infection studies, even after second-line treatment fails. These results demonstrate the complexity and seriousness of co-infection epidemiology, treatment, follow-up, and margin of success. Aggravated by facto…
Yin Mon Thant
…sition plan of fully oral treatment for DR-TB. Furthermore, TB/HIV collaborative activities are established nationwide. With the impact of the coronavirus disease 2019 (COVID-19) pandemic, it is inevitable to have setbacks in the management of TB, together with other non-COVID di…
T.I. Danilova, Yu.V. Korneev, D.А. Kudlаy, N. Yu. Nikolenko
… and extensive drug resistance (MDR/XDR MTB). Patients with TB/HIV co-infection providethe significant impact on the situation. The objective of the study is to assess outcomes of chemotherapy regimens containing bedaquiline in patients with MDR/XDR TB including those with concur…